SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-16-010471
Filing Date
2016-06-03
Accepted
2016-06-03 16:40:46
Documents
2
Period of Report
2016-06-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4_060316gannon.html 4  
1 OWNERSHIP DOCUMENT f4_060316gannon.xml 4 4151
2 POWER OF ATTORNEY exh_241.htm EX-24.1 5317
  Complete submission text file 0001171843-16-010471.txt   10840
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY A0 V5G 4W8
Business Address
GANNON STEVEN (Reporting) CIK: 0001643085 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 161696275